Graham Parry's Stock Ratings

JP Morgan Analyst

Graham Parry is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/17/2025

Updated: Dec 17, 2025

Overall Average Return

-%

Smart Score

1.48%

Overall Average Return Percentile

-

Number of Ratings

2
Buy NowGet Alert
02/27/2023PARRBuy Now
Par Pacific Hldgs
$38.56-24.79%$27 → $29MaintainsNeutralGet Alert
02/05/2018SHPGBuy Now
Shire
——$236 → $237MaintainsBuyGet Alert

Recent Analyst Stock Rating News

BofA Says GlaxoSmithKline's Decision To Halt Feladilimab Studies Is Disappointing
BofA Says GlaxoSmithKline's Decision To Halt Feladilimab Studies Is Disappointing
GlaxoSmithKline plc (NYSE: GSK) announced the termination of the Phase II and Phase III studies of feladilimab, its ICOS receptor agonist in head and neck cancer. This comes as a disappointment, as the candidate could potentially address a multimillion-dollar market, according to BofA Securities.
Gottlieb's Departure Creates Uncertainty For Tobacco, Biopharma, Cannabis Industries
Gottlieb's Departure Creates Uncertainty For Tobacco, Biopharma, Cannabis Industries
BofA Upgrades Sanofi, Names 3 Growth Drivers For Pharma Stock
BofA Upgrades Sanofi, Names 3 Growth Drivers For Pharma Stock
UPDATE: Bank of America Upgrades Novartis AG to Neutral on Sector Re-Rating
UPDATE: Bank of America Upgrades Novartis AG to Neutral on Sector Re-Rating
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved